Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 36, 1981 - Issue 2
1
Views
0
CrossRef citations to date
0
Altmetric
Original articles

Traitement A Long Terme De L’Hypertension Arterielle Severe Avec Le Minoxidil, Nouveau Vasodilatateur Puissant

, &
Pages 77-86 | Published online: 17 May 2016
 

Summary

Twenty-five severe hypertensive patients uncontrolable with conventional medication either because of resistance or because of dose limiting sideeffects received minoxidil, a powerful new vasodilator, for a total period of 300 months (1 to 36 months-mean duration: 12 months).

Mean daily dosage varied from 15 mg during the first month (25 patients) to 47 mg at the 18th month (7 patients). Compared with initial values measured under conventional treatment (230/130), systolic and diastolic blood pressures dropped 20 % during the first month (180/100) and more than 40% at 18 months (130/80). During the following months these good results were maintaind with similar doses of minoxidil.

Increased heart rate and cardiac output, hyperreninemia and fluid retention are usual physiological consequences of vasodilators. Therefore, betaadrenergic blocking agents and diuretics, sometimes in very large doses, have to be used with minoxidil.

Hirsutism is a frequent side effect. It represents a serious limitation to the use of the drug in females and led to a drop-out of 5 of them.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.